PRENT Denmark ApS (Prent Corporation)
Is this your company? Claim this profile
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
PRENT Denmark ApS (Prent Corporation) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:2010
Employees:805
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
North America
Regulatory Approvals
Drug Approval 4Y589M
EMA · #APR-YSKW8THR · 2018-08-01
Drug Approval MAXNUV
FDA · #APR-BCZVFD3I · 2018-05-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-3SW6S73K
Issued: 2020-06-02
Expires: 2025-10-17
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-SORC032A
Issued: 2020-08-13
Expires: 2025-04-23
WHO GMP
World Health Organization
Cert #: CERT-PDOW0ZFJ
Issued: 2020-04-14
Expires: 2025-01-20
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-HZH2PNRG
Issued: 2020-02-06
Expires: 2025-02-12
Loading CDMO intelligence...
Key facts about PRENT Denmark ApS (Prent Corporation)
- PRENT Denmark ApS (Prent Corporation) is headquartered in China.
- PRENT Denmark ApS (Prent Corporation) was founded in 2010.
- PRENT Denmark ApS (Prent Corporation) has 805 employees.
- PRENT Denmark ApS (Prent Corporation)'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like PRENT Denmark ApS (Prent Corporation)
Directory pages this company appears in, each with the full list of matching manufacturers.